These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7848887)

  • 1. Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoral mass and low beta 2 microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase.
    Rodriguez J; Pugh WC; Romaguera JE; Luthra R; Hagemeister FB; McLaughlin P; Rodriguez MA; Swan F; Cabanillas F
    Ann Oncol; 1994 Nov; 5(9):847-9. PubMed ID: 7848887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study.
    Cazals-Hatem D; Lepage E; Brice P; Ferrant A; d'Agay MF; Baumelou E; Brière J; Blanc M; Gaulard P; Biron P; Schlaifer D; Diebold J; Audouin J
    Am J Surg Pathol; 1996 Jul; 20(7):877-88. PubMed ID: 8669537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary mediastinal large B-cell lymphoma: a single-center study of clinicopathologic characteristics.
    Kolonić SO; Dzebro S; Kusec R; Planinc-Peraica A; Dominis M; Jaksić B
    Int J Hematol; 2006 May; 83(4):331-6. PubMed ID: 16757434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.
    Popat U; Przepiork D; Champlin R; Pugh W; Amin K; Mehra R; Rodriguez J; Giralt S; Romaguera J; Rodriguez A; Preti A; Andersson B; Khouri I; Claxton D; de Lima M; Donato M; Anderlini P; Gajewski J; Cabanillas F; van Besien K
    J Clin Oncol; 1998 Jan; 16(1):63-9. PubMed ID: 9440724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous non-Hodgkin's lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement.
    Visco C; Medeiros LJ; Jones D; Smith T; Rodriguez MA; McLaughlin P; Romaguera J; Cabanillas F; Sarris AH
    Ann Oncol; 2002 Aug; 13(8):1290-9. PubMed ID: 12181254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of primary mediastinal large B-cell lymphomas].
    Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
    Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mediastinal large B-cell lymphoma. A retrospective anatomic-clinical study of 26 cases].
    Tchen N; Eghbali H; Soubeyran P; Trojani M; Richaud P; Bonnel C; Quénel-Tueux N; Hoerni B
    Bull Cancer; 1997 Jul; 84(7):704-8. PubMed ID: 9339196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients.
    Zinzani PL; Martelli M; Bertini M; Gianni AM; Devizzi L; Federico M; Pangalis G; Michels J; Zucca E; Cantonetti M; Cortelazzo S; Wotherspoon A; Ferreri AJ; Zaja F; Lauria F; De Renzo A; Liberati MA; Falini B; Balzarotti M; Calderoni A; Zaccaria A; Gentilini P; Fattori PP; Pavone E; Angelopoulou MK; Alinari L; Brugiatelli M; Di Renzo N; Bonifazi F; Pileri SA; Cavalli F;
    Haematologica; 2002 Dec; 87(12):1258-64. PubMed ID: 12495899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) in diffuse large B-cell lymphoma: association with clinical characteristics and outcome.
    Terol MJ; Tormo M; Martinez-Climent JA; Marugan I; Benet I; Ferrandez A; Teruel A; Ferrer R; García-Conde J
    Ann Oncol; 2003 Mar; 14(3):467-74. PubMed ID: 12598355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage chemotherapy and autologous stem cell transplantation are inferior for relapsed or refractory primary mediastinal large B-cell lymphoma compared with diffuse large B-cell lymphoma.
    Kuruvilla J; Pintilie M; Tsang R; Nagy T; Keating A; Crump M
    Leuk Lymphoma; 2008 Jul; 49(7):1329-36. PubMed ID: 18604722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience.
    Escalón MP; Liu NS; Yang Y; Hess M; Walker PL; Smith TL; Dang NH
    Cancer; 2005 May; 103(10):2091-8. PubMed ID: 15816054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group.
    Abou-Elella AA; Weisenburger DD; Vose JM; Kollath JP; Lynch JC; Bast MA; Bierman PJ; Greiner TC; Chan WC; Armitage JO
    J Clin Oncol; 1999 Mar; 17(3):784-90. PubMed ID: 10071267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary mediastinal large B-cell lymphoma: clinical study of a distinct clinical entity and treatment outcome in 20 patients: review of the literature.
    Andreopoulou E; Pectasides D; Dimopoulos MA; Nikolaides C; Fountzilas G; Valsami S; Economopoulos T
    Am J Clin Oncol; 2004 Jun; 27(3):312-6. PubMed ID: 15170155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of primary mediastinal B-cell lymphoma with sclerosis.
    Brugger W; Engelhardt R; Mertelsmann R; Kanz L
    Ann Oncol; 1994 Dec; 5(10):943-7. PubMed ID: 7535081
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary mediastinal large B-cell lymphoma: a single-institution clinical study in Japan.
    Sekiguchi N; Nishimoto J; Tanimoto K; Kusumoto S; Onishi Y; Watanabe T; Kobayashi Y; Asamura H; Kagami Y; Matsuno Y; Tobinai K
    Int J Hematol; 2004 Jun; 79(5):465-71. PubMed ID: 15239397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of serum beta 2 microglobulin as an indicator of early relapse in diffuse large cell lymphoma.
    Avilés A; Narváez BR; Díaz-Maqueo JC; Guzmán R; Talavera A; García EL
    Leuk Lymphoma; 1993 Mar; 9(4-5):377-80. PubMed ID: 7688627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary mediastinal large B-cell lymphoma: the need for prospective controlled clinical trials.
    Bieri S; Roggero E; Zucca E; Bertoni F; Pianca S; Sanna P; Pedrinis E; Bernier J; Cavalli F
    Leuk Lymphoma; 1999 Nov; 35(5-6):537-44. PubMed ID: 10609791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics and prognosis of diffuse large B-cell lymphoma].
    Yang BY; Yong WB; Zhu J; Zheng W; Zhang YT; Wang XP; Meng SN
    Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):174-6. PubMed ID: 15946571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma.
    De Sanctis V; Finolezzi E; Osti MF; Grapulin L; Alfò M; Pescarmona E; Berardi F; Natalino F; Moleti ML; Di Rocco A; Enrici RM; Foà R; Martelli M
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1154-60. PubMed ID: 18472357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk classification for large cell lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinase.
    Suki S; Swan F; Tucker S; Fritsche HA; Redman JR; Rodriguez MA; McLaughlin P; Romaguera J; Hagemeister FB; Velasquez WS
    Leuk Lymphoma; 1995 Jun; 18(1-2):87-92. PubMed ID: 8580834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.